Grabar Law Office In the News: Alto Neuroscience Execs Sued Over Rosy Drug Claims
By Grabar Law |
An Alto Neuroscience investor claims CEO Amit Etkin and other directors overstated the efficacy of the psychiatric biotech company's lead ...
Read More 
Grabar Law Office In the News: Marijuana Vape Antitrust Actions Consolidated In Calif.
By Grabar Law |
Five proposed antitrust class actions brought by buyers of CCell brand cannabis vape accusing the Chinese manufacturers and U.S. distributors ...
Read More 
Grabar Law Office In the News: DOJ Asks for Stay in PVC Antitrust Case Amid Criminal Probe
By Grabar Law |
The U.S. Department of Justice is asking an Illinois federal court to pause discovery in a case accusing polyvinyl chloride ...
Read More 
Grabar Law Office In the News: Biotech Replimune Faces Derivative Suit Over Trial Claims
By Grabar Law |
Executives and directors of biotechnology company Replimune Group Inc. face shareholder derivative claims that they concealed issues affecting a clinical ...
Read More 
Grabar Law Office In the News: Biotech Replimune Faces Derivative Suit Over Trial Claims
By Grabar Law |
Executives and directors of biotechnology company Replimune Group Inc. face shareholder derivative claims that they concealed issues affecting a clinical ...
Read More 
Grabar Law Office Files Federal Lawsuit Against Major Insulin Manufacturers and PBMs on Behalf of the University of Pennsylvania
By Grabar Law |
Grabar Law Office has filed a complaint on behalf of The Trustees of the University of Pennsylvania in the United ...
Read More 
Grabar Law Office In the News: Geron Shareholder Sues Execs Over Drug Launch Claims
By Grabar Law |
A shareholder of Geron Corp. has filed a derivative suit against current and former members of the biopharmaceutical company's top ...
Read More 
Grabar Law Office In the News: AI Audio Co. Brass Accused of Acquisition Accounting Errors
By Grabar Law |
Executives and directors of California-based voice recognition technology company SoundHound Inc. were hit with a shareholder derivative suit alleging they ...
Read More 
Grabar Law Office In The News: Block’s Dorsey, Others Face Derivative Suit Over AML Woes
By Grabar Law |
Officers and directors of Square and Cash App parent company Block Inc. face a shareholder derivative complaint over alleged anti-money ...
Read More 
Grabar Law Office In The News: Micron CEO Accused Of Insider Trading In Fla. Investor Suit
By Grabar Law |
A Micron Technology Inc. shareholder has accused the company CEO and several board members of insider trading after selling $70 million worth ...
Read More 
GRABAR LAW OFFICE FILES SHAREHOLDER DERIVATIVE COMPLAINT AGAINST THE OFFICERS AND DIRECTORS OF PAYPAL HOLDINGS, INC.
By Grabar Law |
This stockholder derivative action is brought on behalf of PayPal against certain current and former PayPal executives and members of ...
Read More 
GRABAR LAW OFFICE FILES SHAREHOLDER DERIVATIVE COMPLAINT AGAINST THE OFFICERS AND DIRECTORS OF ABBOTT LABORATORIES INC. 
By Grabar Law |
As alleged in the Complaint, During the Relevant Period, the Individual Defendants breached their fiduciary duties and violated the federal ...
Read More 
Grabar Law Office Files Shareholder Derivative Complaint Against the Officers and Directors of Romeo Power Inc. (NYSE: RMO)
By Grabar Law |
As alleged in the Complaint, the Company repeatedly represented that it had “secured $300 million in revenue” (a figure that ...
Read More 
Grabar Law Office Files Shareholder Derivative Complaint Against the Officers and Directors of Lucid Group, Inc. (NASDAQ: LCID)
By Grabar Law |
It is alleged the Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts ...
Read More 
Grabar Law Office Files Shareholder Derivative Complaint Against Officers and Directors of QuantumScape Corporation
By Grabar Law |
This stockholder derivative action is brought on behalf of QuantumScape against certain current and former members of the Company’s Board ...
Read More 
Grabar Law Office Files Shareholder Derivative Complaint Against Officers and Directors of Intrusion, Inc.
By Grabar Law |
This stockholder derivative action is brought on behalf of Intrusion, Inc. against certain members of the Company’s Board of Directors ...
Read More 
GRABAR LAW OFFICE INVESTIGATES POTENTIAL CLAIMS AGAINST OFFICERS AND DIRECTORS OF VOLTA, INC. (NYSE: VLTA)
By Grabar Law |
A federal securities fraud class action against complaint has been filed Against Volta, Inc. and certain of its officers and ...
Read More 
GRABAR LAW OFFICE INVESTIGATES POTENTIAL CLAIMS AGAINST OFFICERS AND DIRECTORS OF ODONATE THERAPEUTICS, INC. AFTER AN AGREEMENT IS REACHED TO SETTLE CLASS ACTION
By Grabar Law |
Odonate Therapeutics Inc. (OTC: ODTC) has agreed to pay $12.5 million to resolve a proposed securities class action in alleging ...
Read More 
GRABAR LAW OFFICE FILES COMPLAINT PURSUANT TO 8 DEL. C. § 220 TO COMPEL INSPECTION OF BOOKS AND RECORDS OF CLOVER HEALTH INVESTMENTS CORP.
By Grabar Law |
Plaintiff wishes to inspect books and records relating to meetings of Clover Health’s Board of Directors (the “Board”) regarding materially ...
Read More 
GRABAR LAW OFFICE FILES COMPLAINT PURSUANT TO 8 DEL. C. § 220 TO COMPEL INSPECTION OF BOOKS AND RECORDS OF QUANTUMSCAPE CORPORATION
By Grabar Law |
According to the Complaint, Plaintiff wishes to inspect books and records relating to meetings of QuantumScape’s Board of Directors (the ...
Read More